Related Experiment Video

Updated: Aug 24, 2026

Modeling Cataract Surgery in Mice
05:19

Modeling Cataract Surgery in Mice

Published on: December 1, 2023

Calpains: targets of cataract prevention?

Suman Biswas1, Frederick Harris, Sarah Dennison

  • 1Department of Ophthalmology, Royal Preston Hospital, Preston, PR2 9HT, UK.

Trends in Molecular Medicine
|April 23, 2004
PubMed

Insights

Unregulated calpain activity contributes to cataract formation. Structure-based design of calpain inhibitors offers a promising non-surgical treatment for this vision-impairing condition.

Area of Science:

  • Biochemistry
  • Ophthalmology
  • Molecular Biology

Background:

  • Calpains (calcium-dependent proteases) are implicated in lens protein degradation.
  • Unregulated calpain activity is a potential cause of cataracts in humans and animals.

Purpose of the Study:

  • To explore the role of calpains in cataractogenesis.
  • To investigate the potential of calpain inhibitors as anti-cataract agents.

Main Methods:

  • Analysis of emerging evidence on calpain-mediated proteolysis in the lens.
  • Leveraging recently solved calpain structures for inhibitor design.

Main Results:

  • Calpain-mediated proteolysis of lens proteins is a significant factor in cataract development.
  • Structure-based design enables the creation of potent calpain inhibitors.

Conclusions:

  • Calpain inhibitors represent a novel therapeutic strategy for certain types of cataracts.
  • These inhibitors offer a potential alternative to cataract surgery, improving quality of life globally.

More Related Videos

Characterization of Molecular Mechanisms of In vivo UVR Induced Cataract13:56

Characterization of Molecular Mechanisms of In vivo UVR Induced Cataract

Published on: November 28, 2012

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...